{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:41:47Z","timestamp":1781707307180,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>This study aimed to investigate the effect of the presence of metabolic syndrome (MetS) on the limb volume and quality of life (QoL) of patients who underwent complex decongestive therapy (CDT) due to unilateral breast cancer-related lymphedema (BCRL).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Forty female patients with unilateral BCRL, of whom 20 had MetS (MetS group) and 20 did not have MetS (control group), were included in the study. The participants received CDT 5\u00a0days a week for 3\u00a0weeks. The participants\u2019 limb volume (percentage of excess volume (PEV) and percentage reduction of excess volume (PREV) was determined using a tape measure, and their QoL was assessed using the Lymphedema Quality of Life questionnaire (LYMQoL) before and after treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After the treatment, the PEV and PREV values and LYMQoL-symptoms scores of the patients improved (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05); however, the LYMQoL-function, appearance\/body image, mood\/emotions, and overall QoL scores did not change in the MetS group (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). In the control group, the PEV and PREV values and the LYMQoL-appearance\/body image, mood\/emotions, and overall QoL scores improved (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), but the LYMQoL-symptoms and LYMQoL-function scores did not change (<jats:italic>p<\/jats:italic>\u2009&gt;\u20090.05). There was a greater increase in the post-treatment PEV and PREV values of the control group compared to the MetS group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The study yielded that CDT was an effective treatment in BCRL with and without MetS; however, the improvement was greater in BCRL cases without MetS than in those with MetS. Therefore, the presence of MetS should be taken into account in the treatment of lymphedema in patients who develop BCRL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov, <jats:italic>identifier<\/jats:italic>: NCT05426993. Registered 2022\u201306-16. <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/search?cond=NCT05426993\">https:\/\/clinicaltrials.gov\/search?cond=NCT05426993<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-024-08676-z","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T14:04:18Z","timestamp":1719842658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A comparative evaluation of the efficacy of complete decongestive therapy in the treatment of unilateral breast cancer\u2013related lymphedema with and without metabolic syndrome"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3921-0721","authenticated-orcid":false,"given":"Cansu Sahbaz","family":"Pirincci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6585-7617","authenticated-orcid":false,"given":"Oguzhan","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7796-2588","authenticated-orcid":false,"given":"Mustafa Ertugrul","family":"Yasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7341-2888","authenticated-orcid":false,"given":"Meltem","family":"Dalyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,29]]},"reference":[{"issue":"5","key":"8676_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome\u2014a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23(5):469\u2013480. https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01858.x","journal-title":"Diabet Med"},{"issue":"10","key":"8676_CR2","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","volume":"119","author":"A Galassi","year":"2006","unstructured":"Galassi A, Reynolds K, He J (2006) Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 119(10):812\u2013819. https:\/\/doi.org\/10.1016\/j.amjmed.2006.02.031","journal-title":"Am J Med"},{"issue":"20","key":"8676_CR3","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","volume":"112","author":"PW Wilson","year":"2005","unstructured":"Wilson PW, D\u2019Agostino RB, Parise H, Sullivan L, Meigs JB (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112(20):3066\u20133072. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.539528","journal-title":"Circulation"},{"key":"8676_CR4","doi-asserted-by":"publisher","first-page":"943162","DOI":"10.1155\/2014\/943162","volume":"2014","author":"J Kaur","year":"2014","unstructured":"Kaur J (2014) A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014:943162. https:\/\/doi.org\/10.1155\/2014\/943162","journal-title":"Cardiol Res Pract"},{"issue":"4","key":"8676_CR5","doi-asserted-by":"publisher","first-page":"e34916","DOI":"10.1371\/journal.pone.0034916","volume":"7","author":"CL Edwardson","year":"2012","unstructured":"Edwardson CL, Gorely T, Davies MJ, Gray LJ, Khunti K, Wilmot EG, Yates T, Biddle SJ (2012) Association of sedentary behaviour with metabolic syndrome: a meta-analysis. PLoS One 7(4):e34916. https:\/\/doi.org\/10.1371\/journal.pone.0034916","journal-title":"PLoS One"},{"issue":"4","key":"8676_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nm0410-400","volume":"16","author":"DM Erion","year":"2010","unstructured":"Erion DM, Shulman GI (2010) Diacylglycerol-mediated insulin resistance. Nat Med 16(4):400\u2013402. https:\/\/doi.org\/10.1038\/nm0410-400","journal-title":"Nat Med"},{"issue":"4","key":"8676_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/01.sap.0000257149.42922.7e","volume":"59","author":"AG Warren","year":"2007","unstructured":"Warren AG, Brorson H, Borud LJ, Slavin SA (2007) Lymphedema: a comprehensive review. Ann Plast Surg 59(4):464\u2013472. https:\/\/doi.org\/10.1097\/01.sap.0000257149.42922.7e","journal-title":"Ann Plast Surg"},{"issue":"6","key":"8676_CR8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1089\/lrb.2018.0032","volume":"17","author":"JA Goss","year":"2019","unstructured":"Goss JA, Maclellan RA, Greene AK (2019) Adult-onset primary lymphedema: a clinical-lymphoscintigraphic study of 26 patients. Lymphat Res Biol 17(6):620\u2013623. https:\/\/doi.org\/10.1089\/lrb.2018.0032","journal-title":"Lymphat Res Biol"},{"issue":"6","key":"8676_CR9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jaad.2017.03.022","volume":"77","author":"AA Grada","year":"2017","unstructured":"Grada AA, Phillips TJ (2017) Lymphedema: pathophysiology and clinical manifestations. J Am Acad Dermatol 77(6):1009\u20131020. https:\/\/doi.org\/10.1016\/j.jaad.2017.03.022","journal-title":"J Am Acad Dermatol"},{"key":"8676_CR10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-319-14493-1_4","volume-title":"Epidemiology and morbidity of lymphedema","author":"AK Greene","year":"2015","unstructured":"Greene AK (2015) Epidemiology and morbidity of lymphedema. Presentation, Diagnosis, and Treatment, Lymphedema, pp 33\u201344"},{"key":"8676_CR11","first-page":"14","volume-title":"Lymphedema etiology, epidemiology and clinical staging","author":"S Michelini","year":"2010","unstructured":"Michelini S (2010) Lymphedema etiology, epidemiology and clinical staging. Compression therapy in lymphatic Insufficiency. Milano, Cizeta-Medicali, pp 14\u201318"},{"issue":"3","key":"8676_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.5606\/tftrd.2018.3539","volume":"64","author":"P Borman","year":"2018","unstructured":"Borman P (2018) Lymphedema diagnosis, treatment, and follow-up from the view point of physical medicine and rehabilitation specialists. Turk J Phys Med Rehabil 64(3):179\u2013197. https:\/\/doi.org\/10.5606\/tftrd.2018.3539","journal-title":"Turk J Phys Med Rehabil"},{"issue":"6","key":"8676_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14(6):500\u2013515. https:\/\/doi.org\/10.1016\/S1470-2045(13)70076-7","journal-title":"Lancet Oncol"},{"key":"8676_CR14","first-page":"3","volume":"53","author":"Executive Committee of the International Society of Lymphology","year":"2020","unstructured":"Executive Committee of the International Society of Lymphology (2020) The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the international society of lymphology. Lymphology 53:3\u201319","journal-title":"Lymphology"},{"issue":"1","key":"8676_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1089\/lrb.2019.0072","volume":"20","author":"P Doruk Analan","year":"2022","unstructured":"Doruk Analan P, Kaya E (2022) Is there a relationship between insulin resistance and breast cancer-related lymphedema? A preliminary study. Lymphat Res Biol 20(1):76\u201381. https:\/\/doi.org\/10.1089\/lrb.2019.0072","journal-title":"Lymphat Res Biol"},{"issue":"12","key":"8676_CR16","doi-asserted-by":"publisher","first-page":"e52021","DOI":"10.1371\/journal.pone.0052021","volume":"7","author":"S Lin","year":"2012","unstructured":"Lin S, Kim J, Lee MJ, Roche L, Yang NL, Tsao PS, Rockson SG (2012) Prospective transcriptomic pathway analysis of human lymphatic vascular insufficiency: identification and validation of a circulating biomarker panel. PLoS ONE 7(12):e52021. https:\/\/doi.org\/10.1371\/journal.pone.0052021","journal-title":"PLoS ONE"},{"issue":"19","key":"8676_CR17","doi-asserted-by":"publisher","first-page":"11359","DOI":"10.3390\/ijms231911359","volume":"23","author":"KM Yusof","year":"2022","unstructured":"Yusof KM, Groen K, Rosli R, Abdullah M, Mahmud R, Avery-Kiejda KA (2022) Evaluation of circulating MicroRNAs and adipokines in breast cancer survivors with arm lymphedema. Int J Mol Sci 23(19):11359. https:\/\/doi.org\/10.3390\/ijms231911359","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"8676_CR18","doi-asserted-by":"publisher","first-page":"E94","DOI":"10.1111\/j.1749-6632.2010.05752.x","volume":"1207","author":"S Chakraborty","year":"2010","unstructured":"Chakraborty S, Zawieja S, Wang W, Zawieja DC, Muthuchamy M (2010) Lymphatic system: a vital link between metabolic syndrome and inflammation. Ann N Y Acad Sci 1207(Suppl 1):E94\u2013E102. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05752.x. (Suppl 1)","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"8676_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/lrb.2017.0086","volume":"17","author":"B Duyur Cak\u0131t","year":"2019","unstructured":"Duyur Cak\u0131t B, Pervane Vural S, Ayhan FF (2019) Complex decongestive therapy in breast cancer-related lymphedema: does obesity affect the outcome negatively? Lymphat Res Biol 17(1):45\u201350. https:\/\/doi.org\/10.1089\/lrb.2017.0086","journal-title":"Lymphat Res Biol"},{"key":"8676_CR20","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3389\/fphys.2019.01402","volume":"10","author":"X Jiang","year":"2019","unstructured":"Jiang X, Tian W, Nicolls MR, Rockson SG (2019) The lymphatic system in obesity, insulin resistance, and cardiovascular diseases. Front Physiol 10:1402. https:\/\/doi.org\/10.3389\/fphys.2019.01402","journal-title":"Front Physiol"},{"issue":"2","key":"8676_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1089\/lrb.2017.0051","volume":"16","author":"A Chachaj","year":"2018","unstructured":"Chachaj A, Pu\u0142a B, Chabowski M et al (2018) Role of the lymphatic system in the pathogenesis of hypertension in humans. Lymphat Res Biol 16(2):140\u2013146. https:\/\/doi.org\/10.1089\/lrb.2017.0051","journal-title":"Lymphat Res Biol"},{"key":"8676_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1741-7015-12-115","volume":"12","author":"RH Eckel","year":"2014","unstructured":"Eckel RH, Cornier MA (2014) Update on the NCEP ATP-III emerging cardiometabolic risk factors. BMC Med 12:115. https:\/\/doi.org\/10.1186\/1741-7015-12-115","journal-title":"BMC Med"},{"issue":"5","key":"8676_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.breast.2012.12.018","volume":"22","author":"SF Liao","year":"2013","unstructured":"Liao SF, Li SH, Huang HY, Chen ST, Kuo SJ, Chen DR, Wei TS (2013) The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of lymphedema severity and response to CDP in breast cancer-related lymphedema (BCRL). Breast 22(5):703\u2013706. https:\/\/doi.org\/10.1016\/j.breast.2012.12.018","journal-title":"Breast"},{"issue":"3","key":"8676_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5606\/tftrd.2018.2843","volume":"64","author":"P Borman","year":"2018","unstructured":"Borman P, Yaman A, Denizli M, Karahan S, \u00d6zdemir O (2018) The reliability and validity of Lymphedema Quality of Life Questionnaire-Arm in Turkish patients with upper limb lymphedema related with breast cancer. Turk J Phys Med Rehabil 64(3):205\u2013212. https:\/\/doi.org\/10.5606\/tftrd.2018.2843. (Published 2018 Jul 9)","journal-title":"Turk J Phys Med Rehabil"},{"issue":"4","key":"8676_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/archsurg.133.4.45","volume":"133","author":"DS Ko","year":"1998","unstructured":"Ko DS, Lerner R, Klose G, Cosimi AB (1998) Effective treatment of lymphedema of the extremities. Arch Surg 133(4):452\u2013458. https:\/\/doi.org\/10.1001\/archsurg.133.4.45","journal-title":"Arch Surg"},{"issue":"1","key":"8676_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.soncn.2012.11.004","volume":"29","author":"BB Lasinski","year":"2013","unstructured":"Lasinski BB (2013) Complete decongestive therapy for treatment of lymphedema. Semin Oncol Nurs 29(1):20\u201327. https:\/\/doi.org\/10.1016\/j.soncn.2012.11.004","journal-title":"Semin Oncol Nurs"},{"issue":"2","key":"8676_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/bf03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175\u2013191. https:\/\/doi.org\/10.3758\/bf03193146","journal-title":"Behav Res Methods"},{"issue":"1","key":"8676_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1037\/a0024338","volume":"141","author":"CO Fritz","year":"2012","unstructured":"Fritz CO, Morris PE, Richler JJ (2012) Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen 141(1):2\u201318. https:\/\/doi.org\/10.1037\/a0024338","journal-title":"J Exp Psychol Gen"},{"key":"8676_CR29","doi-asserted-by":"publisher","unstructured":"Lenhard W, Lenhard A (2022) Computation of effect sizes. Psychometrica. https:\/\/doi.org\/10.13140\/RG.2.2.17823.92329","DOI":"10.13140\/RG.2.2.17823.92329"},{"issue":"2","key":"8676_CR30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI (2022) Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci 23(2):786. https:\/\/doi.org\/10.3390\/ijms23020786","journal-title":"Int J Mol Sci"},{"issue":"4","key":"8676_CR31","first-page":"206","volume":"37","author":"P van der Veen","year":"2004","unstructured":"van der Veen P, De Voogdt N, Lievens P, Duquet W, Lamote J, Sacre R (2004) Lymphedema development following breast cancer surgery with full axillary resection. Lymphology 37(4):206\u2013208","journal-title":"Lymphology"},{"issue":"1","key":"8676_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1148\/radiology.180.1.2052688","volume":"180","author":"RS Werner","year":"1991","unstructured":"Werner RS, McCormick B, Petrek J, Cox L, Cirrincione C, Gray JR, Yahalom J (1991) Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology 180(1):177\u2013184. https:\/\/doi.org\/10.1148\/radiology.180.1.2052688","journal-title":"Radiology"},{"issue":"7","key":"8676_CR33","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1097\/GOX.0b013e3182a96359","volume":"1","author":"AK Greene","year":"2013","unstructured":"Greene AK, Maclellan RA (2013) Obesity-induced upper extremity lymphedema. Plast Reconstr Surg Glob Open 1(7):e59. https:\/\/doi.org\/10.1097\/GOX.0b013e3182a96359","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"8676_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/328592","author":"M Khan","year":"2014","unstructured":"Khan M, Joseph F (2014) Adipose tissue and adipokines: the association with and application of adipokines in obesity. Scientifica. https:\/\/doi.org\/10.1155\/2014\/328592","journal-title":"Scientifica"},{"issue":"5","key":"8676_CR35","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/ijo.2012.98","volume":"37","author":"N Arngrim","year":"2013","unstructured":"Arngrim N, Simonsen L, Holst JJ, B\u00fclow J (2013) Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects: a possible link between obesity and local tissue inflammation? Int J Obes (Lond) 37(5):748\u2013750. https:\/\/doi.org\/10.1038\/ijo.2012.98","journal-title":"Int J Obes (Lond)"},{"issue":"7","key":"8676_CR36","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.2337\/db12-0844","volume":"62","author":"M Haemmerle","year":"2013","unstructured":"Haemmerle M, Keller T, Egger G et al (2013) Enhanced lymph vessel density, remodeling, and inflammation are reflected by gene expression signatures in dermal lymphatic endothelial cells in type 2 diabetes. Diabetes 62(7):2509\u20132529. https:\/\/doi.org\/10.2337\/db12-0844","journal-title":"Diabetes"},{"issue":"11","key":"8676_CR37","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1161\/HYPERTENSIONAHA.122.20166","volume":"79","author":"DL Mattson","year":"2022","unstructured":"Mattson DL (2022) Lymphatics and blood pressure. Hypertension 79(11):2463\u20132464. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.20166","journal-title":"Hypertension"},{"key":"8676_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnut.2019.00129","volume":"6","author":"W van den Brink","year":"2019","unstructured":"van den Brink W, van Bilsen J, Salic K et al (2019) Current and future nutritional strategies to modulate inflammatory dynamics in metabolic disorders. Front Nutr 6:129. https:\/\/doi.org\/10.3389\/fnut.2019.00129","journal-title":"Front Nutr"},{"issue":"1","key":"8676_CR39","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.4081\/oncol.2012.e2","volume":"6","author":"T Paraskevi","year":"2012","unstructured":"Paraskevi T (2012) Quality of life outcomes in patients with breast cancer. Oncol Rev 6(1):e2. https:\/\/doi.org\/10.4081\/oncol.2012.e2. (Published 2012 Jan 30)","journal-title":"Oncol Rev"},{"issue":"35","key":"8676_CR40","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.1200\/JCO.2008.16.4731","volume":"26","author":"RL Ahmed","year":"2008","unstructured":"Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR (2008) Lymphedema and quality of life in breast cancer survivors: the Iowa Women\u2019s Health Study. J Clin Oncol 26(35):5689\u20135696. https:\/\/doi.org\/10.1200\/JCO.2008.16.4731","journal-title":"J Clin Oncol"},{"issue":"5","key":"8676_CR41","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1089\/lrb.2017.0061","volume":"16","author":"D Sezgin Ozcan","year":"2018","unstructured":"Sezgin Ozcan D, Dalyan M, Unsal Delialioglu S, Duzlu U, Polat CS, Koseoglu BF (2018) Complex decongestive therapy enhances upper limb functions in patients with breast cancer-related lymphedema. Lymphat Res Biol 16(5):446\u2013452. https:\/\/doi.org\/10.1089\/lrb.2017.0061","journal-title":"Lymphat Res Biol"},{"issue":"4","key":"8676_CR42","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5606\/tftrd.2017.779","volume":"63","author":"H Yesil","year":"2017","unstructured":"Yesil H, Eyig\u00f6r S, Caramat \u0130, I\u015f\u0131k R (2017) Effects of complex decongestive therapy on quality of life, depression, neuropathic pain, and fatigue in women with breast cancer-related lymphedema. Turk J Phys Med Rehabil 63(4):329\u2013334. https:\/\/doi.org\/10.5606\/tftrd.2017.779. (Published 2017 Nov 13)","journal-title":"Turk J Phys Med Rehabil"},{"issue":"6","key":"8676_CR43","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3109\/0284186X.2013.774461","volume":"52","author":"L Koch","year":"2013","unstructured":"Koch L, Jansen L, Herrmann A, Stegmaier C, Holleczek B, Singer S, Brenner H, Arndt V (2013) Quality of life in long-term breast cancer survivors \u2014 a 10-year longitudinal population-based study. Acta Oncol 52(6):1119\u20131128. https:\/\/doi.org\/10.3109\/0284186X.2013.774461","journal-title":"Acta Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08676-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08676-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08676-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T09:20:56Z","timestamp":1721035256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08676-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,29]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["8676"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08676-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,29]]},"assertion":[{"value":"13 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Clinical Research Ethics Committee of the hospital (approval number: E2-22\u20131805). Participants\u2019 informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"473"}}